The Latest Cardiac and Vascular News
CLEVELAND–(BUSINESS WIRE)–ScottCare Cardiovascular Solutions (www.scottcare.com) announced that it has signed an agreement with Ninety One Holding, Inc. (www.91.life) to become a principal distributor for Ninety One’s cloud software platform for cardiac implanted device monitoring, effectively expanding the partnership between the two firms. Currently, ScottCare’s 24/7 remote cardiac monitoring service, Ambucor, […]
October 2021 ISSN 2152-4343 Abstract Objective. Arteriovenous fistula (AVF) creation is an important procedure for hemodialysis in chronic renal failure (CRF) patients. Recent advancements in vascular access have resulted in endovascular AVF (endoAVF) creations. EndoAVFs are less invasive and less expensive when placed. The dilation of the perforator vein pre-procedure is crucial […]
-The acquisition and funding will support commercialization of the company’s personalized decision support solutions to serve millions of seniors and their caregivers via mobile applications, with a special focus on Medicare Advantage ASHEVILLE, N.C., Oct. 21, 2021 /PRNewswire/ — ilumivu, Inc., a pioneer in predictive and personalized healthcare intervention software utilized at university […]
SAN CARLOS, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA] a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the treatment of the first patient in its Phase III pivotal CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial for patients […]
GENT, Belgium–(BUSINESS WIRE)–FEops, a cloud-based digital health player in the structural heart space, is glad to announce the nomination of Euan Thomson as a board member to its Board of Directors. “We are delighted to welcome Euan to the FEops Board of Directors. His wealth of knowledge and extensive expertise […]
VANCOUVER, British Columbia–(BUSINESS WIRE)–Evasc Neurovascular is proud to announce the third generation of its eCLIPs™ device, the eCLIPs Bifurcation Flow Diverter. The new device is classified as a flow diverter, with a leaf density of 35%, which is 60% higher than the existing eCLIPs devices. As a result, the new […]
MIAMI, Oct. 20, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announced today the activation of two new clinical sites for the currently enrolling ELPIS II Trial, evaluating Lomecel-B injection into the myocardium of […]
MONMOUTH JUNCTION, N.J., Oct. 20, 2021 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using CytoSorb®1 blood purification, makes additional comments on the investigator-initiated REMOVE study following the formal presentation of trial results on Saturday, October 16th at the European Association for Cardio-Thoracic Surgery (EACTS) annual meeting in Barcelona, Spain. […]
BOSTON, Oct. 20, 2021 /PRNewswire/ — Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that it received a Refusal to File letter from the United States Food and Drug Administration (FDA) regarding Stealth’s New Drug Application […]
– Third-quarter sales growth of 23.4 percent; organic sales growth of 22.4 percent – GAAP diluted EPS from continuing operations growth of 69.6 percent; adjusted diluted EPS growth of 42.9 percent – Global COVID-19 testing-related sales were $1.9 billion in the third quarter – Excluding COVID-19 testing-related sales, third-quarter sales […]
